FTCA Protection for Naloxone Prescribing and Dispensing
A recent Determination of Coverage provides that, under specific circumstances, the dispensing and prescribing of Naloxone to non-health center patients is protected by the Federal Tort Claims Act (FTCA) program. On August 17, [...]